T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.84B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.13B |
| 3 |
Elanco Animal Health
ELAN
|
+$1.1B |
| 4 |
Bank of America
BAC
|
+$860M |
| 5 |
JB Hunt Transport Services
JBHT
|
+$618M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.19B |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$1.55B |
| 3 |
JPMorgan Chase
JPM
|
+$1.29B |
| 4 |
Booking.com
BKNG
|
+$1.06B |
| 5 |
Merck
MRK
|
+$757M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.47% |
| 2 | Healthcare | 18.48% |
| 3 | Consumer Discretionary | 13.62% |
| 4 | Financials | 13.47% |
| 5 | Communication Services | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Brown-Forman Class B
BF.B
$11.9B
| $34.3M | 0.01% |
650,690
-383
| -0.1% | -$18.6K |
|
1002
Hartford Financial Services
HIG
$34.1B
| $34.3M | 0.01% |
690,070
+36,400
| +6% | +$1.73M |
|
1003
Criteo S.A.
CRTO
$774M
| $34.3M | 0.01% |
1,711,084
-471,280
| -22% | -$12M |
|
1004
Carter's
CRI
$1.14B
| $34M | 0.01% |
337,146
-1,838
| -0.5% | -$164K |
|
1005
Unifirst Corp
UNF
$4.69B
| $33.9M | 0.01% |
220,955
+27,487
| +14% | +$3.86M |
|
|
PDCE
1006
DELISTED
PDC Energy, Inc.
PDCE
| $33.7M | 0.01% |
829,053
-518,642
| -38% | -$18.9M |
|
|
CCF
1007
DELISTED
Chase Corporation
CCF
| $33.7M | 0.01% |
364,229
+9
| +0% | +$857 |
|
1008
American Vanguard Corp
AVD
$52.8M
| $33.7M | ﹤0.01% |
1,954,959
-19,593
| -1% | -$346K |
|
1009
DaVita
DVA
$11.4B
| $33.6M | ﹤0.01% |
618,836
-231,152
| -27% | -$12.8M |
|
1010
Bloom Energy
BE
$77.4B
| $33.5M | ﹤0.01% |
2,594,857
-339,306
| -12% | -$4.15M |
|
|
HI
1011
DELISTED
Hillenbrand
HI
| $33.4M | ﹤0.01% |
805,305
-67,030
| -8% | -$2.83M |
|
1012
Ziff Davis
ZD
$1.91B
| $33.3M | ﹤0.01% |
442,244
+1,105
| +0.3% | +$76.3K |
|
1013
Ameren
AEE
$27.5B
| $33.2M | ﹤0.01% |
451,790
+29,060
| +7% | +$2.02M |
|
1014
CytomX Therapeutics
CTMX
$586M
| $33.2M | ﹤0.01% |
3,090,673
-1,000,853
| -24% | -$14.8M |
|
1015
Hercules Capital
HTGC
$3.16B
| $33.2M | ﹤0.01% |
2,623,935
-147,926
| -5% | -$1.88M |
|
1016
Iovance Biotherapeutics
IOVA
$4.98B
| $33.2M | ﹤0.01% |
3,492,734
+187,707
| +6% | +$1.82M |
|
|
RUTH
1017
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $33M | ﹤0.01% |
1,288,433
+42,261
| +3% | +$1.03M |
|
1018
Madrigal Pharmaceuticals
MDGL
$11.9B
| $32.8M | ﹤0.01% |
261,537
+518
| +0.2% | +$64.4K |
|
1019
A.O. Smith
AOS
$7.93B
| $32.7M | ﹤0.01% |
614,021
+36,824
| +6% | +$1.83M |
|
1020
Quanex
NX
$888M
| $32.7M | ﹤0.01% |
2,059,964
+21,100
| +1% | +$335K |
|
1021
Chipotle Mexican Grill
CMG
$40.3B
| $32.7M | ﹤0.01% |
2,301,600
+95,000
| +4% | +$1.1M |
|
1022
Generac Holdings
GNRC
$12.1B
| $32.5M | ﹤0.01% |
634,443
+1,768
| +0.3% | +$92.2K |
|
1023
Ameris Bancorp
ABCB
$5.47B
| $32.3M | ﹤0.01% |
939,379
+72,158
| +8% | +$2.68M |
|
1024
Ovintiv
OVV
$16.5B
| $31.8M | ﹤0.01% |
878,694
+4,832
| +0.6% | +$166K |
|
|
AAT
1025
American Assets Trust
AAT
$1.33B
| $31.8M | ﹤0.01% |
693,479
+2,415
| +0.3% | +$104K |
|
Similar funds
T. Rowe Price Associates's Q1 2019 Portfolio in Review
As of Q1 2019, T. Rowe Price Associates held 2,615 positions worth $680B, up 15% from $591B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q1 2019 filing shows 56 new, 1,633 increased, 713 reduced and 86 closed positions. Its largest new stake was Fox Class B: 11,707,204 shares worth $420M. The largest sale was Tesla, an estimated $2.19B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2019 buy was Fox Class B: 11,707,204 shares worth $420M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q1 2019, an estimated $2.84B increase.
- T. Rowe Price Associates's biggest Q1 2019 reduction was Tesla, cutting an estimated $2.19B.
- T. Rowe Price Associates fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $1.55B.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $680B portfolio in Q1 2019.
- T. Rowe Price Associates opened 56 new positions and closed 86 in Q1 2019.
- T. Rowe Price Associates's portfolio value rose 15% quarter-over-quarter to $680B.
Based on T. Rowe Price Associates's 13F filing for Q1 2019, filed 15 May 2019.